Ember 3 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ember 3. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ember 3 Today - Breaking & Trending Today

HR+/HER2- Breast Cancer: Inhibiting the PI3K/AKT/mTOR Pathway

Published: August 8, 2023

Dr Vidal expands on use of PI3K/AKT/mTOR pathway inhibitors following frontline progression, focusing on the PI3K inhibitor alpelisib for patients with PIK3CA mutations, as well as capivasertib, an AKT inhibitor in development.

Source: onclive.com

Related Topics:

Aditya BardiaGregory VidalKomal JhaveriHr Her2 Breast CancerCdk4 6 InhibitorsSecond Line TherapiesEndocrine TherapyEndocrine ResistanceAkt InhibitorsCapitello 291Maintain TrialEmber 3Oral SerdsViktoria 1